Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report

Abstract Background SARS-CoV-19 infection is associated with an increased risk of thrombotic events. We present a case of acute middle cerebral artery ischemic stroke in a patient with SARS-CoV-19 infection despite being on warfarin with supratherapeutic INR (International Normalized Ratio). Case pr...

Full description

Bibliographic Details
Main Authors: Gokhan Demir, Rama Hommos, Sally Sami Al-Sirhan, Hashem Abu Serhan, Muhannad Haddadin, Umar Bin Rashid, Yamane Chawa
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Journal of Medical Case Reports
Subjects:
Online Access:https://doi.org/10.1186/s13256-023-03936-8
_version_ 1797811484181397504
author Gokhan Demir
Rama Hommos
Sally Sami Al-Sirhan
Hashem Abu Serhan
Muhannad Haddadin
Umar Bin Rashid
Yamane Chawa
author_facet Gokhan Demir
Rama Hommos
Sally Sami Al-Sirhan
Hashem Abu Serhan
Muhannad Haddadin
Umar Bin Rashid
Yamane Chawa
author_sort Gokhan Demir
collection DOAJ
description Abstract Background SARS-CoV-19 infection is associated with an increased risk of thrombotic events. We present a case of acute middle cerebral artery ischemic stroke in a patient with SARS-CoV-19 infection despite being on warfarin with supratherapeutic INR (International Normalized Ratio). Case presentation A 68-year-old Caucasian female with multiple comorbidities was admitted to the hospital with symptoms of upper respiratory tract infection. A rapid antigen test confirmed the diagnosis of COVID-19 pneumonia, and intravenous remdesivir was initiated. On the fifth day of admission, the patient experienced sudden onset confusion, slurred speech, left-sided hemiplegia, right-sided eye deviation, and left-sided facial droop. Imaging studies revealed an occlusion of the distal anterior M2 segment of the right middle cerebral artery, and an MRI of the brain confirmed an acute right MCA infarction. Notably, the patient was receiving warfarin therapy with a supratherapeutic INR of 3.2. Conclusions This case report highlights the potential for thromboembolic events, including stroke, in patients with COVID-19 infection, even when receiving therapeutic anticoagulation therapy. Healthcare providers should be vigilant for signs of thrombosis in COVID-19 patients, particularly those with pre-existing risk factors. Further research is necessary to understand the pathophysiology and optimal management of thrombotic complications in COVID-19 patients.
first_indexed 2024-03-13T07:24:15Z
format Article
id doaj.art-5aefb2c5b65e4041b866173cd2a8c3a0
institution Directory Open Access Journal
issn 1752-1947
language English
last_indexed 2024-03-13T07:24:15Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Journal of Medical Case Reports
spelling doaj.art-5aefb2c5b65e4041b866173cd2a8c3a02023-06-04T11:29:46ZengBMCJournal of Medical Case Reports1752-19472023-05-011711510.1186/s13256-023-03936-8Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case reportGokhan Demir0Rama Hommos1Sally Sami Al-Sirhan2Hashem Abu Serhan3Muhannad Haddadin4Umar Bin Rashid5Yamane Chawa6Department of Internal Medicine, Hamad General HospitalCollege of Medicine, Qatar UniversityCollege of Medicine, Qatar UniversityDepartment of Ophthalmology, Hamad General HospitalDepartment of Internal Medicine, Hamad General HospitalDepartment of Internal Medicine, Hamad General HospitalDepartment of Internal Medicine, Hamad General HospitalAbstract Background SARS-CoV-19 infection is associated with an increased risk of thrombotic events. We present a case of acute middle cerebral artery ischemic stroke in a patient with SARS-CoV-19 infection despite being on warfarin with supratherapeutic INR (International Normalized Ratio). Case presentation A 68-year-old Caucasian female with multiple comorbidities was admitted to the hospital with symptoms of upper respiratory tract infection. A rapid antigen test confirmed the diagnosis of COVID-19 pneumonia, and intravenous remdesivir was initiated. On the fifth day of admission, the patient experienced sudden onset confusion, slurred speech, left-sided hemiplegia, right-sided eye deviation, and left-sided facial droop. Imaging studies revealed an occlusion of the distal anterior M2 segment of the right middle cerebral artery, and an MRI of the brain confirmed an acute right MCA infarction. Notably, the patient was receiving warfarin therapy with a supratherapeutic INR of 3.2. Conclusions This case report highlights the potential for thromboembolic events, including stroke, in patients with COVID-19 infection, even when receiving therapeutic anticoagulation therapy. Healthcare providers should be vigilant for signs of thrombosis in COVID-19 patients, particularly those with pre-existing risk factors. Further research is necessary to understand the pathophysiology and optimal management of thrombotic complications in COVID-19 patients.https://doi.org/10.1186/s13256-023-03936-8StrokeSARS-CoV-19IschemiaInfarctionINRMiddle cerebral artery
spellingShingle Gokhan Demir
Rama Hommos
Sally Sami Al-Sirhan
Hashem Abu Serhan
Muhannad Haddadin
Umar Bin Rashid
Yamane Chawa
Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report
Journal of Medical Case Reports
Stroke
SARS-CoV-19
Ischemia
Infarction
INR
Middle cerebral artery
title Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report
title_full Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report
title_fullStr Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report
title_full_unstemmed Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report
title_short Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report
title_sort ischemic stroke in the setting of supratherapeutic international normalized ratio following coronavirus disease 2019 infection a case report
topic Stroke
SARS-CoV-19
Ischemia
Infarction
INR
Middle cerebral artery
url https://doi.org/10.1186/s13256-023-03936-8
work_keys_str_mv AT gokhandemir ischemicstrokeinthesettingofsupratherapeuticinternationalnormalizedratiofollowingcoronavirusdisease2019infectionacasereport
AT ramahommos ischemicstrokeinthesettingofsupratherapeuticinternationalnormalizedratiofollowingcoronavirusdisease2019infectionacasereport
AT sallysamialsirhan ischemicstrokeinthesettingofsupratherapeuticinternationalnormalizedratiofollowingcoronavirusdisease2019infectionacasereport
AT hashemabuserhan ischemicstrokeinthesettingofsupratherapeuticinternationalnormalizedratiofollowingcoronavirusdisease2019infectionacasereport
AT muhannadhaddadin ischemicstrokeinthesettingofsupratherapeuticinternationalnormalizedratiofollowingcoronavirusdisease2019infectionacasereport
AT umarbinrashid ischemicstrokeinthesettingofsupratherapeuticinternationalnormalizedratiofollowingcoronavirusdisease2019infectionacasereport
AT yamanechawa ischemicstrokeinthesettingofsupratherapeuticinternationalnormalizedratiofollowingcoronavirusdisease2019infectionacasereport